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Abstract 
Introduction: Individuals with chronic musculoskeletal pain show impairments in 
their pain-modulatory capacity. Stress-induced analgesia (SIA) is a paradigm of 
endogenous pain inhibition mainly tested in animals. It has not been tested in 
patients with chronic pain despite the important role of stress in pain modulation and 
the chronicity process. 
Methods: SIA was tested in 22 patients with chronic musculoskeletal pain and 18 
healthy participants matched for age and gender. Pain thresholds, pain tolerance and 
suprathreshold pain sensitivity were examined before and after a cognitive stressor. 
Additionally, chronic stress levels, pain catastrophizing and pain characteristics were 
assessed as potential modulating factors. 
Results: Patients with chronic musculoskeletal pain compared to healthy controls 
showed significantly impaired SIA (F(1,37)=5.63, p=.02) for pain thresholds, but not 
pain tolerance (F(1,37)=0.05, p=.83) and stress-induced hyperalgesia (SIH) to 
suprathreshold pain ratings (F(1,37)=7.76, p=.008). Patients (r(22)=-0.50, p=.05) but 
not controls (r(18)=-0.39, p=.13) with high catastrophizing had low SIA as assessed 
by pain thresholds. In controls suprathreshold pain ratings were significantly 
positively correlated with catastrophizing (r(18)=0.57, p=.03) and life-time stress 
exposure (r(18)=0.54, p=.03). In patients neither catastrophizing (r(22)=0.21, p=.34) 
nor stress exposure (r(22)=0.34, p=.34) were associated with suprathreshold SIH. 
Discussion: Our data suggest impairments of SIA and SIH in patients with chronic 
musculoskeletal pain. Catastrophizing was associated with deficient SIA in the 
patients and higher pain ratings in controls. High life time stress also increased pain 
ratings in the controls  
 
3 
 
Keywords: stress-induced analgesia, descending inhibition, stress-induced 
hyperalgesia, musculoskeletal pain, chronic pain 
  
4 
 
Summary 
Patients with chronic musculoskeletal pain compared to controls show deficient 
stress-induced analgesia and stress-induced hyperalgesia to a cognitive stressor.  
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Introduction 
Mechanisms of endogenous pain modulation represent the body’s ability to regulate 
pain responses by activating regulatory pathways such as the descending inhibitory 
pain pathways. Previous research, using painful stimulation within a conditioned pain 
modulation (CPM) paradigm as an activating stimulus for the descending pain-
inhibitory system, has shown that patients with chronic pain often show deficiencies 
in pain inhibition [31]. However, it would also be interesting to employ pain-inhibitory 
stimuli that do not involve painful stimulation to establish the generality of deficient 
pain inhibition beyond nociceptive stimulation. Stress-induced analgesia (SIA) is such 
a paradigm, where an acute non-pain-related stressor inhibits pain perception. SIA 
involves stressors such as social isolation [40] or restraint stress [7] in animals and 
video game playing [25] or exposure to mental arithmetic plus noise [19; 61] in 
humans. Stress has been proposed as an important factor in the onset of pain 
chronicity [3; 56], and patients with fibromyalgia perceive stress as an aggravating 
factor for their pain [37], show elevated stress reactivity [53] and an impaired 
circadian rhythm of blood cortisol levels [10]. Further, acute stress impairs pain 
inhibition in CPM in healthy persons [23; 36] and patients with fibromyalgia [6]. 
However, deficiencies in SIA have not been systematically studied in chronic pain 
populations. Stress cannot only induce analgesia, but also hyperalgesia. This 
bidirectional modulation was associated with the duration of immobilization stress in 
rats, with analgesia after a single exposure and hyperalgesia after a repetition over 7 
days[7]. Further, stress-induced hyperalgesia (SIH) could be induced in patients with 
fibromyalgia, but not in controls when pressure pain thresholds were used as a test 
stimulus [8], while SIH was present in controls when thermal pain thresholds were 
used as a test stimulus [8; 43]. 
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Psychological factors can modulate the response to stress and pain [33]. The 
exposure to chronic stress may augment the responsiveness of the hypothalamic-
pituitary-adrenal (HPA) axis to subsequent stressors [11]. High pain catastrophizing 
has been associated with flattened morning salivary cortisol profile [41] and reduced 
pain inhibition in a CPM paradigm [55; 58] and a paradigm on exercise-induced 
analgesia [4], and therefore may be interfering with SIA. Further, the spatial extent of 
pain was reported to be higher in back pain patients who were exposed to stressful 
life-events, such as a psychological trauma [52], compared to patients without trauma 
exposure. A high spatial extent of clinical pain has been associated with lower heat 
and cold pain thresholds in pain-free body sites [21], and a higher number of pain 
areas has been associated with lower levels of pain inhibition in a CPM paradigm in 
patients with chronic back pain [22]. Therefore, clinical pain extent may be associated 
with pain-inhibitory capacity. 
In this study we set out to investigate (1) if SIA is impaired in patients with chronic 
musculoskeletal pain (2) the influence of psychological factors on SIA, hypothesizing 
that SIA would be impaired in subjects with higher catastrophizing, increased life-time 
exposure to chronic stress and patients with a higher spatial extent of their pain. 
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Methods 
Participants 
Twenty-two patients (15 women, age: mean (M)=55.90 standard deviation 
(SD)=12.36, see Table 1 for demographic and clinical data) with chronic localized 
and widespread musculoskeletal back pain (of whom 9 fulfilled the diagnostic criteria 
for fibromyalgia by Wolfe et al [60]) and 18 healthy controls (15 women, age: 
M=52.94, SD=11.93) participated in this study. Participants with comorbid mental 
disorders, infections, neurological disorders, possible pregnancy, cardiovascular 
problems or brain injuries were excluded. Patients refrained from their acute 
medication (e.g. nonsteroidal anti-inflammatory drugs, NSAIDs; muscle relaxants) in 
agreement with their physician one to three days before prior to testing (one day for 
NSAIDs, three days for muscle relaxants and other acute medication other than 
NSAIDs). The Ethics Committee of the Medical Faculty Mannheim, University of 
Heidelberg, Germany, approved the study and written informed consent was 
obtained from each participant. 
 Patients with 
chronic pain 
Healthy 
controls 
Group test 
Chi²/t(df), p 
N (male/female) 22 (7/15) 18 (3/15) Chi²(1)=0.54, p=.54 
Age: M±SD 56.55±12.43 52.94±11.93 t(36.45)=-0.76, p=.54 
HADS Anxiety: M±SD 7.09±3.12 5.28±2.22 t(34.67)=-2.05, p=.08 
HADS Depression: M±SD 13.32±2.44 13.48±1.64 t(35.28)=0.35, p=.73 
PRSS Catastrophizing: M±SD 1.54±0.95 0.41±0.42 t(30.81)=-3.96, p=.003 
PRSS Active Coping: M±SD 3.08±0.79 4.14±0.73 t(36.33)=3.30, p=.008 
TICS Stress: M±SD 1.54±0.58 0.84±0.38 t(35.58)=-2.60, p=0.03 
MPI pain severity: M±SD 3.05±1.30 n.a. n.a. 
MPI interference: M±SD 2.34±1.69 n.a. n.a. 
MPI affective distress: M±SD 2.38±0.73 n.a. n.a. 
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MPI support: M±SD 2.63±1.28 n.a. n.a. 
MPI self-control: M±SD 2.26±1.64 n.a. n.a. 
WPI Widespread Pain: M±SD 6.50±4.10 n.a. n.a. 
SS Symptom Severity: M±SD 4.07±3.36 n.a. n.a. 
CPG Chronic Pain Grade: Median (IQR) 2(1-3) n.a. n.a. 
Table 1: Demographic and clinical characteristics of the patients and controls. Significant differences 
(p<.05) are depicted in bold. HADS: Hospital Anxiety and Depression Scale, PRSS: Pain-Related Self 
Statements Scale, TICS: Trier Inventory of Chronic Stress; MPI: Multidimensional Pain Inventory; WPI: 
Widespread Pain Index, SS: Symptom Severity Scale, CPG: Chronic Pain Grade, M: mean, SD: 
standard deviation, df: degrees of freedom, IQR: Interquartile range; n.a.: not applicable. 
 
Clinical pain assessments 
Prior to the experiments, the participants completed the Chronic Pain Grade (CPG 
[57]), the Fibromyalgia Symptom Scale (FS [60]), the Pain-Related Self Statements 
Scale (PRSS [17]) and the Multidimensional Pain Inventory (MPI). The CPG [57] is a 
seven-item instrument that measures chronic pain severity in the two dimensions 
intensity and disability. It classifies patients into five hierarchical grades: Grade 0 
(pain free), Grade I (low disability–low intensity), Grade II (low disability–high 
intensity), Grade III (high disability–moderately limiting) and Grade IV (high disability–
severely limiting). It was found to be valid and reliable for use in a general population 
as a self-completion questionnaire [47]. The FS [60] assesses the severity of 
fibromyalgia symptoms on two different scales. The Widespread Pain Index (WPI) 
assesses pain or tenderness in 19 body regions. When summed, these items result 
in a score between 0 and 19. The Symptom Severity Scale assesses additional 
somatic, cognitive and affective symptoms related to fibromyalgia. When summed, 
these items result in a score between 0 and 12. The FS was shown to have a 
sensitivity of 96.6% and a specificity of 91.8% for the diagnosis of fibromyalgia. The 
PRSS [17] assesses catastrophizing and active coping and is a German language 
equivalent of the Coping Strategies Questionnaire [44]. It has excellent reliability 
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(α=.92 for catastrophizing and α=.88 for active coping) and validity, as shown by 
significantly higher values for pain catastrophizing and significantly lower values for 
active coping in pain patients compared to healthy controls, and low to moderate 
correlations with other pain-related variables such as amount of daily activities, 
affective distress or pain severity. The MPI assesses patients’ pain severity, 
interference of the pain, self-control, negative mood and social support. The MPI has 
been used in a large number of studies with a diverse sample of chronic pain patients 
and has excellent reliability and validity [20; 30]. 
Psychological assessments  
Prior to the experiments, the participants completed the Hospital Anxiety and 
Depression Scale (HADS [48]), and a short version of the Trier Inventory of Chronic 
Stress (TICS [45]). The TICS [45] measures chronic stress with a mean score of six 
scales (work overload, worries, social stress, lack of social recognition, work 
discontent, and intrusive memories). The answers are recorded on a 0–4 rating 
scale, with a total number of 30 items. The scale is validated in German participants 
and has a reliability between α=.84 and α=.91. The HADS [48] assesses anxiety and 
depressive symptoms on 7 items each. The scale has excellent reliability (α ranges 
from 0.78–0.93 for the HADS‐A and from 0.82–0.90 for the HADS‐D). It was found to 
perform well in assessing the symptom severity and caseness of anxiety disorders 
and depression in both somatic, mental disorders and primary care patients and in 
the general population [2]. 
All participants were interviewed by a psychologist using the German version of the 
Structured Clinical Interviews (SCID I and II) for DSM IV Axes I and II disorders [59] 
to assess comorbid mental disorder. One patient fulfilled the criteria of an acute 
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depressive episode and three patients reported a single depressive episode in the 
past. No healthy participant reported any axis I or II disorders. 
Experimental procedure 
All participants were examined on two separate days. On the first day, the difficulty of 
the cognitive stressor was determined to ensure successful stress induction during 
the SIA experiment. The SIA experiment was carried out on the second day. 
Electrical pain thresholds, pain tolerance and suprathreshold pain sensitivity were 
assessed before and after stress induction, see Figure 1 and below for details. 
 
Figure 1: Experimental procedure: first pain threshold and pain tolerance were measured in three 
ascending series followed by a series of 10 stimuli with an intensity corresponding to 50% of the pain 
tolerance intensity. These 10 stimuli were rated on a numerical rating scale with respect to pain 
intensity (0 = not painful; 100 = worst pain imaginable) and unpleasantness (0 = not unpleasant; 100 = 
extremely unpleasant). In the pre-stress scanning phase, 10 electrical stimulation blocks were 
delivered. Before and during stress induction, blood pressure and heart rate data were gathered. 
Before and after the stress induction, subjects were asked to rate the perceived stress before or during 
stress induction respectively on a numerical rating scale (0 = no stress; 100 = extreme stress). Finally, 
as post-stress measurement, application and rating (intensity and unpleasantness) of 10 painful 
stimulus blocks and pain threshold and pain tolerance determination were repeated. 
 
Pain threshold, pain tolerance and suprathreshold pain testing 
Pain perception thresholds and pain tolerance were assessed before and after the 
stressor. For pain site–specific electrical stimulation, a pair of needle electrodes (20 
mm long, 0.35-mm uninsulated tip, 2-mm² stimulation area, model: 9013R0272, 28G, 
Alpine Biomed ApS, Skoviunde, Denmark) was placed subcutaneously at the left 
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lower back, 2 cm lateral to the spine, between L1 and L3 (1 mm needle separation). 
Electric stimuli were applied using a constant current stimulator (model DS7A; 
Digitimer, Hertfordshire, England). The experiment was performed using 
Presentation® software (Version 14.0, http://www.neurobs.com/). The participants 
received ascending electrical stimulation trains (Stimulation train: 8 stimuli of 2ms, 
inter stimulus interval = 112msec, inter train interval = 2sec) via the subcutaneous 
needle electrodes and were instructed to press a button when they felt that the 
stimulus had become just noticeably painful (pain threshold) and when they could no 
longer tolerate a higher stimulus intensity (pain tolerance). Each measure was 
determined three times and the last two trials of each stimulation train were used. 
After the first threshold determination, the stimulation intensity was calibrated at a 
perceived pain intensity rating of 50 on a numerical rating scale (endpoints 0=“no 
pain” and 100=“worst pain imaginable”). The first threshold assessment was 
discarded and 50 percent of the difference between pain threshold and pain 
tolerance were added to the pain threshold, to calculate a preliminary stimulation 
intensity. In test trials (duration 12.5 seconds each, stimulus duration 2ms, 112 
stimuli, inter stimulus interval 112msec) the perceived pain intensity was assessed 
using a numerical rating scale. The stimulation intensity was adapted between the 
test trials to reach a pain intensity rating of 50 out of 100 points, or to reach a rating 
closest possible to 50. The resulting stimulation intensity of each subject was used 
for testing of suprathreshold pain sensitivity. Participants received trains of electrical 
stimulation before and after the stressor. They received 10 stimulation blocks 
(duration 11.8 sec each, stimulus duration 2ms, 105 stimuli, inter stimulus interval = 
112 ms), which were always followed by off blocks of 11.8 seconds duration. The 
mean levels of perceived pain intensity and pain unpleasantness were assessed 
using numerical rating scales with the endpoints 0 (“no pain” / ”not unpleasant) and 
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100 (“worst pain imaginable” / “extremely unpleasant”). In total, four SIA indices were 
derived by subtracting the (1) mean pain threshold, (2) mean pain tolerance, (3) pain 
intensity ratings and (4) pain unpleasantness ratings before the stressor from the 
respective values after the stressor. 
Stress induction 
The stressor used in this study was mental arithmetic combined with white noise. The 
mental arithmetic tasks were similar to those from the Konzentrations- und 
Leistungstest (Concentration and Performance Test: [13; 34]) and were presented by 
a female voice via earphones. Such mental arithmetic tasks have previously shown 
to be effective in the induction of stress [19; 54; 61]. Each task consisted of a series 
of two sets of three numbers (e.g. 5,9,4 and 3,8,11) that had to be added or 
subtracted. If the sum of the second set was smaller than the sum of the first set, the 
second result had to be subtracted, if the sum of the first set was smaller than that of 
the second set, the first result had to be added (i.e. 18+22 in this example). In our 
experiment an additional third arithmetic operation had to be executed after 
subtraction or summation (e.g. 40*2) and the subject had to verbally report the final 
result (i.e. 80 in this example). Each task had to be solved within 30s. In total 
subjects had to solve 30 tasks, resulting in a duration of the stressor of 15 minutes. 
To account for individual cognitive performance, five parallel versions of the mental 
arithmetic task with varying difficulty (based on the arithmetic operations) were 
prepared. The individual difficulty level was determined for each participant on a 
separate day. For that purpose, 5 tasks of the lowest level of difficulty were 
presented. If the participant solved at least three of those, the next level was 
presented. If the participant solved at least three tasks at the second level again, the 
next level was presented. This was continued until the participant made more than 
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one error within a level or the highest level was reached. In the main experiment one 
level above the resulting difficulty level was used for stress induction. In order to 
increase the stressfulness of the task white noise was presented continuously and 
increased from 65 to 80 dB from the first to the last arithmetic calculation. The 
perceived stressfulness of the task was assessed before and after the stressor using 
a numerical rating scale with the endpoints 0 (“no stress”) and 100 (“extreme stress”).  
Physiological stress response: heart rate and blood pressure 
To assess physiological effects of the stressor, blood pressure and heart rate were 
measured with the Criticare 506N vital signs monitor (Criticare Systems Inc., 
Waukesha, USA), using a sampling rate of one per minute. Heart rate and blood 
pressure were measured during a 5 minute resting interval immediately before the 
stress phase and throughout the 15 minutes of the stress phase as well as for 5 
minutes after the stressor.  
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Statistical analysis 
Statistical analyses were performed using RStudio 1.0.143 (RStudio, Inc.) with R 
3.4.0 (The R Foundation for Statistical Computing, https://www.r-project.org/). 
Missing values were imputed using the MICE package in R, applying predictive mean 
matching for numeric variables and a proportional odds model for ordered variables 
(maximum number of imputed values per variable: controls=2, patients=3). Outliers, 
which were defined as values more than two standard deviations above or below the 
respective mean, were removed from the analysis (maximum number of outliers per 
variable: controls=2, patients=2). 
For the perceived stress ratings, systolic and diastolic blood pressure, heart rate as 
well as the SIA variables, analyses of variance were computed with group (healthy 
versus patient) as between and time (baseline versus post) as within effect. We used 
pairwise post-hoc t-tests (false discovery rate, FDR [1] corrected) to compare the SIA 
measures within and between groups. Possible modulatory effects of depressive 
symptom severity, anxiety or pain chronicity on SIA effects were examined using 
correlations of the respective effects with the HADS subscales and the CPG. In 
addition, we correlated the PRSS catastrophizing scale, the TICS and the WPI with 
the difference in pain thresholds, pain tolerance and ratings during the experiment. 
We used the false discovery rate (FDR [1]) to correct for multiple comparisons. 
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Results 
Perceived stress during SIA 
Perceived stress increased significantly after the stressor compared to before (time: 
F(1,33)=78.10, p<.001) but did not significantly differ between healthy participants 
and patients (group: F(1,33)=1.59, p=.22; time*group: F(1,33)=1.01, p=.32)). Heart 
rate, systolic and diastolic blood pressure significantly increased during the stressor 
compared to before the stressor (time: heart rate: F(1,37)=11.26, p=.002; systolic 
blood pressure: F(1,37)=30.68, p<.001; diastolic blood pressure: F(1,37)=15.99, 
p<.001). HR, systolic and diastolic blood pressure did not significantly differ between 
patients and controls (group: heart rate: F(1,37)=0.37, p=.54; systolic blood pressure: 
F(1,37)=0.61, p=.44; diastolic blood pressure: F(1,37)=0.84, p=.36), neither did the 
increase in HR during the stressor (time*group: F(1,37)=0.41, p=.53). However, the 
increase in systolic (time*group: F(1,37)=6.79, p=.01) and diastolic (time*group: 
F(1,37)=5.32, p=.03) blood pressure was significantly higher in patients than controls 
(see Table 2). 
 
Patients with chronic pain Healthy Controls 
 
Before (M±SD) During (M±SD) Before (M±SD) During (M±SD) 
Perceived stress 
(NRS) 
17.11±21.56 64.21±22.50 14.19±21.23 51.56±27.19 
Heart Rate 66.35±11.11 73.24±9.47 65.77±10.59 70.41±9.59 
Blood pressure: 
systolic 
128.22±14.65 144.02±16.52 129.81±16.51 135.12±16.23 
Blood pressure: 
diastolic 
74.19±9.24 82.53±9.23 74.86±10.99 76.84±8.73 
Table 2: Change in perceived stress levels and associated changes in heart rate and blood pressure. 
The table depicts the stress ratings, systolic and diastolic blood pressure and heart rate before and 
during the stressor. All values are depicted as mean (M) and standard deviation (SD). NRS: Numerical 
Rating Scale. 
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Differences between pain patients and healthy individuals in stress-induced pain 
modulation 
For pain thresholds, there was a significant SIA effect (time: F(1,37)=6.56, p=.01) and 
healthy participants showed significantly higher pain thresholds than patients with 
chronic pain (group: F(1,37)=7.85, p=.008). The time x group effect was significant 
(F(1,37)=5.63, p=.02). Post-hoc comparisons of pain thresholds before and after the 
stressor revealed a significant SIA effect for the healthy participants (t(17)=-2.56, 
p=.04), but not for the patients with chronic pain (t(21)=-0.51, p=.62), see Figure 2a. 
There was no significant SIA effect for pain tolerance: F(1,37)=0.16, p=.69). Overall, 
healthy participants showed significantly higher pain tolerance (group: F(1,37)=8.08, 
p=.007) than patients with chronic pain. The time x group effect was not significant 
for pain tolerance (F(1,37)=0.05, p=.83). Post-hoc comparisons of pain tolerance 
before and after the stressor revealed no significant SIA effect for the healthy 
participants (t(17)=0.31, p=.76), or the patients with chronic pain (t(21)=0.31, p=.76), 
see Figure 2b. 
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Figure 2: Group differences in SIA. Thresholds and ratings before and after the stressor are depicted 
as mean and standard error of the mean. Patients with chronic pain are depicted with triangles and 
orange lines, healthy participants are depicted with circles and blue lines. Significant post hoc (FDR 
corrected) differences are labeled with asterisks (*p<.05). Figure 2a (top left) shows electrical pain 
threshold before (pre) and after (post) the stressor, figure 2b (top right) shows electrical pain tolerance 
before (pre) and after (post) the stressor, figure 2c (bottom left) shows pain intensity ratings before 
(pre) and after (post) the stressor, figure 2d (bottom right) shows pain unpleasantness ratings before 
(pre) and after (post) the stressor. 
 
The analysis of the effect of stress on pain intensity and pain unpleasantness ratings 
revealed a significant increase in pain intensity ratings, indicating SIH (time: 
F(1,37)=5.13, p=.03), but not for pain unpleasantness ratings (F(1,37)=0.30, p=.58). 
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Overall, patients with chronic pain did not show significantly higher pain intensity 
(group: F(1,37)=2.55, p=.12) or pain unpleasantness ratings (group: F(1,37)=0.00, 
p=.99) than healthy participants. However, the SIH effect was significantly greater in 
patients with chronic pain compared to healthy participants for pain intensity ratings 
(time*group: F(1,37)=7.76, p=.008) but not pain unpleasantness ratings 
(F(1,37)=2.36, p=.13). Post-hoc comparisons of pain intensity revealed a significant 
SIH effect for patients with chronic pain (t(21)=-3.07, p=.01), but not for healthy 
participants (t(17)=0.75, p=.47), see Figure 2c and 2d. Neither the SIA effect nor the 
supratreshold SIH effect were significantly modulated by depressive symptom 
severity, anxiety or pain chronicity (all r<.30, p>.46). 
Association of affective symptoms and coping with descending inhibition of pain 
Compared to healthy controls, we found significantly higher levels of pain 
catastrophizing, lower levels of active coping and higher levels of chronic stress in 
our sample of patients with chronic musculoskeletal pain, see Table 1. Further, we 
found a significant correlation of pain catastrophizing with the stress effect on pain 
thresholds for patients with chronic musculoskeletal pain (r(22)=-0.50, p=.05), 
indicating lower SIA in patients with high catastrophizing. In healthy participants high 
catastrophizing (r(18)=0.57, p=.03) and increased life-time exposure to stress were 
significantly correlated with SIH effects on pain intensity ratings (r(18)=0.54, p=.03). 
We could not find further significant correlations of the pain-modulatory stress effect 
with pain catastrophizing, chronic stress, or clinical pain extent (all r<.42, p>.21), see 
Table 3.  
 
 Stress effect: pain 
threshold 
Stress effect: pain 
tolerance 
Stress effect: pain 
intensity 
Stress effect: pain 
unpleasantness 
 
Healthy 
r(df), p 
Patients 
r(df), p 
Healthy 
r(df), p 
Patients 
r(df), p 
Healthy 
r(df), p 
Patients 
r(df), p 
Healthy 
r(df), p 
Patients 
r(df), p 
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TICS 
r(18)=-
0.37, 
p=.13 
r(22)=-
0.07, 
p=.90 
r(18)=-
0.42, 
p=.22 
r(22)=-
0.08, 
p=.81 
r(18)=0.54
, p=.03 
r(22)=-
0.34, 
p=.34 
r(18)=-
0.08, 
p=.76 
r(22)=-
0.30, 
p=.52 
PRSS 
Catastro
phizing 
r(18)=-
0.39, 
p=.13 
r(22)=-
0.50, 
p=.05 
r(18)=-
0.33, 
p=.22 
r(22)=-
0.35, 
p=.32 
r(18)=0.57
, p=.03 
r(22)=-
0.21, 
p=.34 
r(18)=0.16
, p=.76 
r(22)=-
0.01, 
p=.95 
WPI 
 r(22)=0.03
, p=.90 
 r(22)=-
0.05, 
p=.81 
 r(22)=-
0.23, 
p=.34 
 r(22)=-
0.16, 
p=.70 
Table 3: Association of stress induced pain-modulation with psychological factors and spatial pain 
extent. The table depicts the correlation of the stress effect on electrical pain thresholds, electrical pain 
tolerance, pain intensity and pain unpleasantness ratings with chronic stress, pain catastrophizing and 
clinical pain extent. Significant correlations (p<.05, fdr corrected) are depicted in bold. TICS: Trier 
Inventory of Chronic Stress, PRSS: Pain-Related Self Statements Scale, WPI: Widespread Pain 
Index, df: degrees of freedom. 
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Discussion and conclusions 
This study investigated if stress-induced pain inhibition is deficient in patients with 
chronic musculoskeletal pain. Further, we examined the association of stress-
induced pain modulation with pain catastrophizing, chronic stress exposure and the 
spatial extent of ongoing clinical pain. We found maladaptive stress-induced pain 
modulation in patients with chronic musculoskeletal pain, which manifested itself as 
deficient SIA for pain threshold and as SIH in suprathreshold measures of pain 
sensitivity. Pain catastrophizing was associated with SIA deficiencies as well as 
increased levels of SIH and chronic stress was related to increased levels of SIH. 
The spatial extent of the clinical pain was neither associated with SIA nor SIH. 
Differences between pain patients and healthy individuals in stress-induced pain 
modulation 
The endogenous regulation of pain is an important homeostatic function [49]. We 
report that the endogenous inhibition of pain by stress is impaired in patients with 
chronic musculoskeletal pain. Previous studies found that stress systems such as the 
hypothalamic-pituitary-adrenal (HPA) axis show a dysregulation in chronic pain, as 
seen by low basal cortisol secretion in patients with fibromyalgia [9]. This 
dysregulation was identified as an important factor driving the development of chronic 
pain, as shown by studies which found that a dysregulation of the circadian cortisol 
profile predicted the development of chronic musculoskeletal pain [35] and a low 
hypothalamic-pituitary-adrenal (HPA) axis response to acute stress at the age of 18 
predicted musculoskeletal pain at the age of 22 [38]. Our data add evidence that the 
capacity to downregulate pain after a stressor is impaired in patients with chronic 
musculoskeletal pain. We further found an increase in perceived pain intensity, i.e. a 
SIH in patients with chronic musculoskeletal pain. Although prior studies using the 
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same stressor found SIA but no SIH responses in healthy subjects [18; 61], 
sensitization rather than habituation has previously been reported in musculoskeletal 
pain patients [12]. Further, hyperalgesia instead of analgesia has been reported 
previously in patients with fibromyalgia in a paradigm of exercise-induced analgesia 
[50] where pain ratings were used. Further, our data are in line with a study using the 
“Trier Social Stress Test“, a standardized procedure to induce psychosocial stress, 
which showed that patients with fibromyalgia displayed a SIH effect, which could not 
be observed in healthy controls [8]. Our results that there is no significant relationship 
between pain extent and SIH indicates that SIH as a maladaptive mechanism of pain 
modulation does not seem to be limited to widespread pain syndromes, but is also 
relevant in localized pain disorders. Both SIA [5] and SIH [27] have been shown to be 
mediated via central mechanisms which induce pain inhibition or facilitation via 
modulation of the descending pathways in the periacqueductal grey and the rostral 
ventromedial medulla. It is therefore plausible that both localized and widespread 
clinical pain are affected by deficiencies in these mechanisms. Future studies should 
examine whether impairments in SIA and SIH can also be found when painful test 
stimuli are applied in non-affected body sites, as pain testing was carried out at the 
site of the clinical pain in the current study. 
Association of psychological factors with stress-induced pain modulation 
Pain catastrophizing is a maladaptive coping style with feelings of helplessness, 
active rumination and excessive magnification of negative cognitions and feelings 
toward the painful situation and is more common in patients with chronic pain [29]. 
Pain catastrophizing was linked to pain severity, pain-related interference, disability 
and depressive symptoms of patients with chronic pain [15; 28; 51]. Longitudinal data 
further show that pain catastrophizing predicted the aggravation of pain in patients 
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with back pain and the development of back pain in formerly healthy individuals [39]. 
The mechanism by which pain catastrophizing modulates the pain experience is not 
completely understood, but it was proposed that catastrophizing amplifies 
sensitization and interferes with endogenous inhibition of pain in the central nervous 
system, including spinal pain processing [15; 16]. We found that SIA and SIH were 
associated with catastrophizing. The modulation of pain by catastrophizing has been 
related to activity in the anterior cingulate cortex (ACC) [24; 46], a brain region which 
is also involved in the inhibitory top-down control of the SIA effect. Further, a study on 
dental pain showed that catastrophizing did not modulate the perceived pain intensity 
per se, but that high catastrophizing was related to an enhanced SIH response [32]. 
This modulatory effect of catastrophizing, however, was not related to ACC activity, 
but to activity in the posterior hippocampus. In summary, pain catastrophizing seems 
to be related to the modulatory effect of stress on pain. Our results add that 
catastrophizing may modulate the SIA response and confirm the association of 
catastrophizing with augmented SIH responses. Future studies should clarify whether 
the enhancement of SIH and the reduction of SIA by catastrophizing share a 
common mechanism, or represent separate pathways. Neuronal targets for possible 
pathways could be the ACC and the hippocampus [5]. 
Our data indicate no significant relationship between chronic stress and SIA. On the 
other hand, higher lifetime stress exposure was associated with SIH in healthy 
participants. SIH has been demonstrated to be associated with experimental 
paradigms which implement longer stressors [27] and is thus more likely to be 
modulated by chronic stress than SIA, which is usually induced in paradigms with 
short stressors [7]. The absence of SIH modulation by chronic stress in patients, for 
whom we found higher lifetime stress exposure than for controls, indicates that the 
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effect of chronic stress may result in maladaptive pain modulation, i.e. SIH, at low 
levels of exposure. Neither SIA nor SIH were mediated by depressive symptoms or 
anxiety, indicating that deficient SIA and SIH are associated with chronic pain as a 
clinical entity and not with comorbid affective symptoms in these patients.  
Limitations 
This study has several limitations. First, there is a high variety in the employed 
experimental paradigms in studies on stress-induced pain modulation (for an 
overview on experimental paradigms on SIA see [5] and [26; 27] for SIH). Especially 
in animal models of SIA, other kinds of stressors, such as exposure to painful 
stimulation, have been employed. Therefore, our results cannot be generalized to all 
SIA paradigms, as differences in experimental parameters may account for 
differences in the effects. Second, our sample included patients with localized and 
wide spread musculoskeletal pain and was too small for a subsample analyses. We 
did not find a relationship between spatial extent of the clinical pain and SIA or SIH. 
However, there may be subgroups of patients who show only changes in either SIA 
or SIH and our sample size did not allow for further examination of such groups. 
Third, blood pressure increases during the stressor were higher in patients than in 
controls and these differences in blood pressure might therefore explain differences 
in stress-induced pain modulation. Increased levels of blood pressure are associated 
with analgesic effects induced by activation of descending inhibition via stimulation of 
arterial baroreceptors [14; 42]. It is therefore unlikely that the increased blood 
pressure responses in our patients explain the lack of SIA in these patients. 
However, changes in stress-reactivity may represent a core symptom in chronic pain 
disorders. Future studies should therefore address the question whether changes in 
stress-induced pain modulation are a mere representation of altered intensity of 
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induced stress levels or represent a change in the nature of the interaction effects of 
stress systems with pain modulatory pathways, such as the descending inhibition of 
pain. 
Conclusion 
The present study uncovers impaired SIA and SIH as possible mechanisms involved 
in chronic musculoskeletal pain. SIA was impaired in patients with chronic 
musculoskeletal pain and patients with high catastrophizing showed the greatest 
deficiencies. Further, healthy participants did not show SIH which may be a result of 
low life-time exposure to stress, since we found a significant correlation of SIH with 
chronic stress levels in the controls. Future research should target the neuronal and 
neurochemical mechanisms underlying these maladaptive effects of stress. 
  
25 
 
Acknowledgments 
This work was supported by grants of the Deutsche Forschungsgemeinschaft to FN 
and HF (SFB1158/B03), to FN (NE 1383/14-1), RDT (SFB1158/S01) and the 
Bundesministerium für Bildung und Forschung (01EC1010D) to HF. 
Author contribution 
ML, SK, PS, SSH, FN & HF designed the study; ML analyzed the data and wrote the 
paper; PS acquired the data, SSH, SK, KU, FN, RDT & HF revised the paper, FN, 
RDT & HF acquired the funding. All authors contributed to the interpretation of the 
data, revised the manuscript, and approved the final version of the manuscript. 
Conflict of interest 
There is no conflict of interest.
26 
 
References 
[1] Benjamini Y, Hochberg Y. Approach to Multiple Testing. Journal of the Royal 
Statistical Society Series B (Methodological) 1995;57(1):289-300. 
[2] Bjelland I, Dahl A, Haug T, Neckelmann D. The validity of the Hospital Anxiety and 
Depression Scale. An updated literature review. Journal of Psychosomatic 
Research 2002;52(2):69. 
[3] Blackburn-Munro G, Blackburn-Munro R. Chronic pain, chronic stress and 
depression: coincidence or consequence? Journal of Neuroendocrinology 
2001;13(12):1009. 
[4] Brellenthin A, Crombie K, Cook D, Sehgal N, Koltyn K. Psychosocial Influences on 
Exercise-Induced Hypoalgesia. Pain Medicine 2017;18(3):538. 
[5] Butler R, Finn D. Stress-induced analgesia. Progress in Neurobiology 
2009;88(3):184. 
[6] Coppieters I, Cagnie B, Nijs J, van Oosterwijck J, Danneels L, De Pauw R, Meeus 
M. Effects of Stress and Relaxation on Central Pain Modulation in Chronic 
Whiplash and Fibromyalgia Patients Compared to Healthy Controls. Pain 
Physician 2016;19(3):119. 
[7] Costa A, Smeraldi A, Tassorelli C, Greco R, Nappi G. Effects of acute and chronic 
restraint stress on nitroglycerin-induced hyperalgesia in rats. Neuroscience 
Letters 2005;383(1-2):7. 
[8] Crettaz B, Marziniak M, Willeke P, Young P, Hellhammer D, Stumpf A, Burgmer 
M. Stress-Induced Allodynia–Evidence of Increased Pain Sensitivity in Healthy 
Humans and Patients with Chronic Pain after Experimentally Induced 
Psychosocial Stress. PLoS ONE 2013;8(8). 
27 
 
[9] Crofford L, Pillemer S, Kalogeras K, Cash J, Michelson D, Kling M, Sternberg E, 
Gold P, Chrousos G, Wilder R. Hypothalamic-pituitary-adrenal axis 
perturbations in patients with fibromyalgia. Arthritis and Rheumatism 
1994;37(11):1583. 
[10] Crofford L, Young E, Engleberg N, Korszun A, Brucksch C, McClure L, Brown M, 
Demitrack M. Basal circadian and pulsatile ACTH and cortisol secretion in 
patients with fibromyalgia and/or chronic fatigue syndrome. Brain, Behavior, 
and Immunity 2004;18(4):314. 
[11] Dallman M. Stress update Adaptation of the hypothalamic-pituitary-adrenal axis 
to chronic stress. Trends in Endocrinology and Metabolism: TEM 
1993;4(2):62. 
[12] Diers M, Schley M, Rance M, Yilmaz P, Lauer L, Rukwied R, Schmelz M, Flor H. 
Differential central pain processing following repetitive intramuscular 
proton/prostaglandin E₂ injections in female fibromyalgia patients and healthy 
controls. European Journal of Pain (London, England) 2011;15(7):716. 
[13] Düker H, Lienert G. Konzentrations-Leistungs-Test (KLT) Hogrefe. Göttingen 
1959. 
[14] Dworkin B, Elbert T, Rau H, Birbaumer N, Pauli P, Droste C, Brunia C. Central 
effects of baroreceptor activation in humans: attenuation of skeletal reflexes 
and pain perception. Proceedings of the National Academy of Sciences of the 
United States of America 1994;91(14):6329. 
[15] Edwards R, Bingham 3rd C, Bathon J, Haythornthwaite J. Catastrophizing and 
pain in arthritis, fibromyalgia, and other rheumatic diseases. Arthritis and 
Rheumatism 2006;55(2):325. 
[16] Edwards R, Smith M, Stonerock G, Haythornthwaite J. Pain-related 
catastrophizing in healthy women is associated with greater temporal 
28 
 
summation of and reduced habituation to thermal pain. The Clinical Journal of 
Pain 2006;22(8):730. 
[17] Flor H, Behle D, Birbaumer N. Assessment of pain-related cognitions in chronic 
pain patients. Behaviour Research and Therapy 1993;31(1):63. 
[18] Flor H, Birbaumer N, Schulz R, Grüsser S, Mucha R. Pavlovian conditioning of 
opioid and nonopioid pain inhibitory mechanisms in humans. European 
Journal of Pain (London, England) 2002;6(5):395. 
[19] Flor H, Grüsser S. Conditioned stress-induced analgesia in humans. European 
Journal of Pain (London, England) 1999;3(4):317. 
[20] Flor H, Rudy T, Birbaumer N, Streit B, Schugens M. The applicability of the West 
Haven-Yale multidimensional pain inventory in German-speaking countries. 
Data on the reliability and validity of the MPI-D. Schmerz (Berlin, Germany) 
1990;4(2):82. 
[21] Gerhardt A, Eich W, Janke S, Leisner S, Treede R, Tesarz J. Chronic 
Widespread Back Pain is Distinct From Chronic Local Back Pain: Evidence 
From Quantitative Sensory Testing, Pain Drawings, and Psychometrics. The 
Clinical Journal of Pain 2016;32(7):568. 
[22] Gerhardt A, Eich W, Treede R, Tesarz J. Conditioned pain modulation in patients 
with nonspecific chronic back pain with chronic local pain, chronic widespread 
pain, and fibromyalgia. Pain 2017;158(3):430. 
[23] Geva N, Pruessner J, Defrin R. Acute psychosocial stress reduces pain 
modulation capabilities in healthy men. Pain 2014;155(11):2418. 
[24] Gracely R, Geisser M, Giesecke T, Grant M, Petzke F, Williams D, Clauw D. 
Pain catastrophizing and neural responses to pain among persons with 
fibromyalgia. Brain: a Journal of Neurology 2004;127(Pt 4):835. 
29 
 
[25] Hoffman H, Doctor J, Patterson D, Carrougher G, Furness 3rd T. Virtual reality 
as an adjunctive pain control during burn wound care in adolescent patients. 
Pain 2000;85(1-2):305. 
[26] Imbe H, Iwai-Liao Y, Senba E. Stress-induced hyperalgesia: animal models and 
putative mechanisms. Frontiers in Bioscience: a Journal and Virtual Library 
2006;11:2179. 
[27] Jennings E, Okine B, Roche M, Finn D. Stress-induced hyperalgesia. Progress 
in Neurobiology 2014;121:1. 
[28] Keefe F, Brown G, Wallston K, Caldwell D. Coping with rheumatoid arthritis pain: 
catastrophizing as a maladaptive strategy. Pain 1989;37(1):51. 
[29] Keefe F, Rumble M, Scipio C, Giordano L, Perri L. Psychological aspects of 
persistent pain: current state of the science. The Journal of Pain 
2004;5(4):195. 
[30] Kerns R, Turk D, Rudy T. The West Haven-Yale Multidimensional Pain Inventory 
(WHYMPI). Pain 1985;23(4):345. 
[31] Lewis G, Rice D, McNair P. Conditioned pain modulation in populations with 
chronic pain: a systematic review and meta-analysis. The Journal of Pain 
2012;13(10):936-944. 
[32] Lin C-S, Niddam D, Hsu M-L, Hsieh J-C. Pain Catastrophizing is Associated with 
Dental Pain in a Stressful Context. Journal of Dental Research 
2013;92(2):130. 
[33] Linton S, Shaw W. Impact of psychological factors in the experience of pain. 
Physical Therapy 2011;91(5):700. 
[34] Lukesch H, Mayrhofer S. KLT-R. Revidierte Fassung des Konzentrations-
Leistungs-Test von H. Düker & GA Lienert.  2001. 
30 
 
[35] McBeth J, Silman A, Gupta A, Chiu Y, Ray D, Morriss R, Dickens C, King Y, 
Macfarlane G. Moderation of psychosocial risk factors through dysfunction of 
the hypothalamic-pituitary-adrenal stress axis in the onset of chronic 
widespread musculoskeletal pain: findings of a population-based prospective 
cohort study. Arthritis and Rheumatism 2007;56(1):360. 
[36] Nilsen K, Christiansen S, Holmen L, Sand T. The effect of a mental stressor on 
conditioned pain modulation in healthy subjects. Scandinavian Journal of Pain 
2017;3(3):142. 
[37] Okifuji A, Turk D. Stress and psychophysiological dysregulation in patients with 
fibromyalgia syndrome. Applied Psychophysiology and Biofeedback 
2002;27(2):129. 
[38] Paananen M, O’Sullivan P, Straker L, Beales D, Coenen P, Karppinen J, Pennell 
C, Smith A. A low cortisol response to stress is associated with 
musculoskeletal pain combined with increased pain sensitivity in young adults: 
a longitudinal cohort study. Arthritis Research & Therapy 2015;17. 
[39] Picavet H, Vlaeyen J, Schouten J. Pain catastrophizing and kinesiophobia: 
predictors of chronic low back pain. American Journal of Epidemiology 
2002;156(11):1028. 
[40] Puglisi-Allegra S, Oliverio A. Social isolation: effects on pain threshold and 
stress-induced analgesia. Pharmacology, Biochemistry, and Behavior 
1983;19(4):679. 
[41] Quartana PJ, Buenaver LF, Edwards RR, Klick B, Haythornthwaite JA, Smith 
MT. Pain Catastrophizing and Salivary Cortisol Responses to Laboratory Pain 
Testing in Temporomandibular Disorder and Healthy Participants. The Journal 
of Pain 2010;11(2):186. 
31 
 
[42] Randich A, Hartunian C. Activation of the sinoaortic baroreceptor reflex arc 
induces analgesia: interactions between cardiovascular and endogenous pain 
inhibition systems. Physiological Psychology 1983;11(3):214-220. 
[43] Reinhardt T, Kleindienst N, Treede R, Bohus M, Schmahl C. Individual 
modulation of pain sensitivity under stress. Pain Medicine 2013;14(5):676. 
[44] Rosenstiel A, Keefe F. The use of coping strategies in chronic low back pain 
patients: relationship to patient characteristics and current adjustment. Pain 
1983;17(1):33. 
[45] Schulz P, Schlotz W, Becker P. Trierer Inventar zum chronischen Stress: TICS: 
Hogrefe, 2004. 
[46] Seminowicz D, Davis K. Cortical responses to pain in healthy individuals 
depends on pain catastrophizing. Pain 2006;120(3):297. 
[47] Smith B, Penny K, Purves A, Munro C, Wilson B, Grimshaw J, Chambers W, 
Smith W. The Chronic Pain Grade questionnaire: validation and reliability in 
postal research. Pain 1997;71(2):141. 
[48] Snaith R, Zigmond A. The Hospital Anxiey and Depression Scale with the 
Irritability-depression-anxiety Scale and the Leeds Situational Anxiety Scale: 
Manual: Nfer-Nelson, 1994. 
[49] Staud R. Abnormal endogenous pain modulation is a shared characteristic of 
many chronic pain conditions. Expert Review of Neurotherapeutics 
2012;12(5):577. 
[50] Staud R, Robinson M, Price D. Isometric exercise has opposite effects on central 
pain mechanisms in fibromyalgia patients compared to normal controls. Pain 
2005;118(1-2):176. 
32 
 
[51] Sullivan M, Thorn B, Haythornthwaite J, Keefe F, Martin M, Bradley L, Lefebvre 
J. Theoretical perspectives on the relation between catastrophizing and pain. 
The Clinical Journal of Pain 2001;17(1):52. 
[52] Tesarz J, Gerhardt A, Leisner S, Janke S, Treede R, Eich W. Distinct 
quantitative sensory testing profiles in nonspecific chronic back pain subjects 
with and without psychological trauma. Pain 2015;156(4):577. 
[53] Thieme K, Turk D, Gracely R, Maixner W, Flor H. The relationship among 
psychological and psychophysiological characteristics of fibromyalgia patients. 
The Journal of Pain 2015;16(2):186. 
[54] Trapp M, Trapp E-M, Egger JW, Domej W, Schillaci G, Avian A, Rohrer PM, 
Hörlesberger N, Magometschnigg D, Cervar-Zivkovic M. Impact of Mental and 
Physical Stress on Blood Pressure and Pulse Pressure under Normobaric 
versus Hypoxic Conditions. PLoS ONE 2014;9(5). 
[55] Traxler J, Hanssen M, Lautenbacher S, Peters M. General versus pain-specific 
cognitions: Pain catastrophizing but not optimism influences conditioned pain 
modulation. European Journal of Pain (London, England) 2018. 
[56] Van Uum S, Sauvé B, Fraser L, Morley-Forster P, Paul T, Koren G. Elevated 
content of cortisol in hair of patients with severe chronic pain: a novel 
biomarker for stress. Stress (Amsterdam, Netherlands) 2008;11(6):483. 
[57] Von Korff M, Ormel J, Keefe F, Dworkin S. Grading the severity of chronic pain. 
Pain 1992;50(2):133. 
[58] Weissman-Fogel I, Sprecher E, Pud D. Effects of catastrophizing on pain 
perception and pain modulation. Experimental Brain Research 
2008;186(1):79. 
33 
 
[59] Wittchen H, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV 
(SKID), Achse 1 [Structured Clinical Interview for DSM-IV (SCID), Axis 1 
Disorders]. Hogrefe, Göttingen 1997. 
[60] Wolfe F, Clauw D, Fitzcharles M, Goldenberg D, Katz R, Mease P, Russell A, 
Russell I, Winfield J, Yunus M. The American College of Rheumatology 
preliminary diagnostic criteria for fibromyalgia and measurement of symptom 
severity. Arthritis Care & Research 2010;62(5):600. 
[61] Yilmaz P, Diers M, Diener S, Rance M, Wessa M, Flor H. Brain correlates of 
stress-induced analgesia. Pain 2010;151(2):522. 
 
 
34 
 
Figure legends 
 
Figure 1: Experimental procedure: first pain threshold and pain tolerance were measured in 
three ascending series followed by a series of 10 stimuli with an intensity corresponding to 
50% of the pain tolerance intensity. These 10 stimuli were rated on a numerical rating scale 
with respect to pain intensity (0 = not painful; 100 = worst pain imaginable) and 
unpleasantness (0 = not unpleasant; 100 = extremely unpleasant). In the pre-stress scanning 
phase, 10 electrical stimulation blocks were delivered. Before and during stress induction, 
blood pressure and heart rate data were gathered. Before and after the stress induction, 
subjects were asked to rate the perceived stress before or during stress induction 
respectively on a numerical rating scale (0 = no stress; 100 = extreme stress). Finally, as 
post-stress measurement, application and rating (intensity and unpleasantness) of 10 painful 
stimulus blocks and pain threshold and pain tolerance determination were repeated. 
 
Figure 2: Group differences in SIA. Thresholds and ratings before and after the stressor are 
depicted as mean and standard error of the mean. Patients with chronic pain are depicted 
with triangles and orange lines, healthy participants are depicted with circles and blue lines. 
Significant post hoc (FDR corrected) differences are labeled with asterisks (*p<.05). Figure 
2a (top left) shows electrical pain threshold before (pre) and after (post) the stressor, figure 
2b (top right) shows electrical pain tolerance before (pre) and after (post) the stressor, figure 
2c (bottom left) shows pain intensity ratings before (pre) and after (post) the stressor, figure 
2d (bottom right) shows pain unpleasantness ratings before (pre) and after (post) the 
stressor. 
